CAR 001 - Caravan Biologix
Alternative Names: CAR-001 - Caravan BiologixLatest Information Update: 03 Feb 2025
Price :
$50 *
At a glance
- Originator Caravan Biologix
- Class Antirheumatics; Gene therapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Rheumatoid arthritis; Systemic lupus erythematosus
Most Recent Events
- 18 Dec 2024 Preclinical trials in Rheumatoid arthritis in USA (Parenteral) before December 2024 (Caravan Biologix pipeline, December 2024)
- 18 Dec 2024 Preclinical trials in Systemic lupus erythematosus in USA (Parenteral) before December 2024 (Caravan Biologix pipeline, December 2024)